Candiac, Quebec
Canada needs to be able to deal with any future pandemics or health emergencies. That is why the Government of Canada, and the Government of Quebec, are investing in the revitalization of the Canadian biomanufacturing and life sciences sector with projects that strengthen our capabilities, while boosting the economy and creating or maintaining hundreds of well-paying jobs.
Today, the Honourable Soraya Martinez Ferrada, Minister responsible for the Economic Development Agency of Canada for the Regions of Quebec, speaking on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, alongside Pierre Fitzgibbon, Quebec Minister of Economy, Innovation and Energy, and Christian Dubé, Quebec Minister of Health, announced a $29.77 million investment through the Strategic Innovation Fund to support Pharmascience Inc.'s $119.33 million project. This contribution will allow Pharmascience to update and expand its facility in Candiac, Quebec, increasing its capacity to produce sterile injectables. The Government of Quebec also announced an investment of $24.75 million toward the same project.
With this project, Pharmascience will be adding over 2,500 square metres to its facility, retrofitting 560 square metres of existing space, making enhancements to automated processes and purchasing new state-of-the-art equipment. This will allow the company to increase its production capacity by 2.5 times and create 47 high-paying jobs.
This contribution aligns with Canada's Biomanufacturing and Life Sciences Strategy and supports the growth of Canada's life science ecosystem and domestic pharmaceutical supply chain.
